1. Gardner, S. D., Field, A. M., Coleman, D. V. & Hulme, B. New human papovavirus (B.K.) isolated from urine after renal transplantation. Lancet 1, 1253–1257 (1971).
2. Hirsch, H. H. & Steiger, J. Polyomavirus BK. Lancet Infect Dis 3, 611–623 (2003).
3. De Gascun, C. F. & Carr, M. J. Human polyomavirus reactivation: disease pathogenesis and treatment approaches. Clin Dev Immunol 2013, 373579 (2013).
4. Sharma, R. & Zachariah, M. BK Virus Nephropathy: Prevalence, Impact and Management Strategies. Int J Nephrol Renovasc Dis 13, 187–192 (2020).
5. Moens, U. et al. Biology, evolution, and medical importance of polyomaviruses: An update. Infect Genet Evol 54, 18–38 (2017).
6. Jin, L., Gibson, P. E., Knowles, W. A. & Clewley, J. P. BK virus antigenic variants: sequence analysis within the capsid VP1 epitope. J Med Virol 39, 50–56 (1993).
7. Knowles, W. A., Gibson, P. E. & Gardner, S. D. Serological typing scheme for BK-like isolates of human polyomavirus. J Med Virol 28, 118–123 (1989).
8. Jin, L., Gibson, P. E., Booth, J. C. & Clewley, J. P. Genomic typing of BK virus in clinical specimens by direct sequencing of polymerase chain reaction products. J Med Virol 41, 11–17 (1993).
9. Morel, V. et al. A Simple and Reliable Strategy for BK Virus Subtyping and Subgrouping. J Clin Microbiol 55, 1177–1185 (2017).
10. Ikegaya, H. et al. Identification of a genomic subgroup of BK polyomavirus spread in European populations. J Gen Virol 87, 3201–3208 (2006).
11. Luo, C., Hirsch, H. H., Kant, J. & Randhawa, P. VP-1 quasispecies in human infection with polyomavirus BK. J Med Virol 84, 152–161 (2012).
12. Pastrana, D. V. et al. BK polyomavirus genotypes represent distinct serotypes with distinct entry tropism. J Virol 87, 10105–10113 (2013).
13. Mesters, J. R., Tan, J. & Hilgenfeld, R. Viral enzymes. Curr Opin Struct Biol 16, 776–786 (2006).
14. Schwarz, A. et al. Viral Origin, Clinical Course, and Renal Outcomes in Patients With BK Virus Infection After Living-Donor Renal Transplantation. Transplantation 100, 844–853 (2016).
15. Knowles, W. A. et al. Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40. J Med Virol 71, 115–123 (2003).
16. Egli, A. et al. Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors. J Infect Dis 199, 837–846 (2009).
17. Bofill-Mas, S., Formiga-Cruz, M., Clemente-Casares, P., Calafell, F. & Girones, R. Potential transmission of human polyomaviruses through the gastrointestinal tract after exposure to virions
or viral DNA. J Virol 75, 10290–10299 (2001).
18. Schubbert, R., Renz, D., Schmitz, B. & Doerfler, W. Foreign (M13) DNA ingested by mice reaches peripheral leukocytes, spleen, and liver via the intestinal wall mucosa and can be covalently
linked to mouse DNA. Proc Natl Acad Sci U S A 94, 961–966 (1997).
19. Goudsmit, J., Wertheim-van Dillen, P., van Strien, A. & van der Noordaa, J. The role of BK virus in acute respiratory tract disease and the presence of BKV DNA in tonsils. J Med Virol 10,
91–99 (1982).
20. Sundsfjord, A. et al. Detection of BK virus DNA in nasopharyngeal aspirates from children with respiratory infections but not in saliva from immunodeficient and immunocompetent adult
patients. J Clin Microbiol 32, 1390–1394 (1994).
21. Pietropaolo, V. et al. Transplacental transmission of human polyomavirus BK. J Med Virol 56, 372–376 (1998).
22. Mazzoni, E. et al. Mother-to-child transmission of oncogenic polyomaviruses BKPyV, JCPyV and SV40. J Infect 80, 563–570 (2020).
23. Monini, P. et al. Latent BK virus infection and Kaposi’s sarcoma pathogenesis. Int J Cancer 66, 717–722 (1996).
24. Dolei, A. et al. Polyomavirus persistence in lymphocytes: prevalence in lymphocytes from blood donors and healthy personnel of a blood transfusion centre. J Gen Virol 81, 1967–1973 (2000).
25. Chatterjee, M., Weyandt, T. B. & Frisque, R. J. Identification of archetype and rearranged forms of BK virus in leukocytes from healthy individuals. J Med Virol 60, 353–362 (2000).
26. Andrews, C. A., Shah, K. V., Daniel, R. W., Hirsch, M. S. & Rubin, R. H. A serological investigation of BK virus and JC virus infections in recipients of renal allografts. J Infect Dis 158, 176–181
(1988).
27. Noda, M., Matsuda, S. & Kobayashi, M. [Virucidal activity of disinfectants: virucidal activities of disinfectants on some viruses coated on several materials and its durability]. Kansenshogaku
Zasshi 74, 1023–1031 (2000).
28. Koskenvuo, M. et al. BK polyomavirus-associated hemorrhagic cystitis among pediatric allogeneic bone marrow transplant recipients: treatment response and evidence for nosocomial trans-
mission. J Clin Virol 56, 77–81 (2013).
29. Kato, J. et al. Nosocomial BK Polyomavirus Infection Causing Hemorrhagic Cystitis Among Patients With Hematological Malignancies After Hematopoietic Stem Cell Transplantation. Am J
Transplant 17, 2428–2433 (2017).
30. Hosoi, H. et al. A cluster of BK polyomavirus-associated hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation. Transpl Infect Dis 23, e13736 (2021).
31. Low, J. A., Magnuson, B., Tsai, B. & Imperiale, M. J. Identification of gangliosides GD1b and GT1b as receptors for BK virus. J Virol 80, 1361–1366 (2006).
32. Moriyama, T., Marquez, J. P., Wakatsuki, T. & Sorokin, A. Caveolar endocytosis is critical for BK virus infection of human renal proximal tubular epithelial cells. J Virol 81, 8552–8562 (2007).
33. Jiang, M., Abend, J. R., Tsai, B. & Imperiale, M. J. Early events during BK virus entry and disassembly. J Virol 83, 1350–1358 (2009).
34. Drachenberg, C. B., Hirsch, H. H., Ramos, E. & Papadimitriou, J. C. Polyomavirus disease in renal transplantation: review of pathological findings and diagnostic methods. Hum Pathol 36,
1245–1255 (2005).
35. Heritage, J., Chesters, P. M. & McCance, D. J. The persistence of papovavirus BK DNA sequences in normal human renal tissue. J Med Virol 8, 143–150 (1981).
36. Vago, L. et al. JCV-DNA and BKV-DNA in the CNS tissue and CSF of AIDS patients and normal subjects. Study of 41 cases and review of the literature. J Acquir Immune Defic Syndr Hum
Retrovirol 12, 139–146 (1996).
37. Dörries, K., Vogel, E., Günther, S. & Czub, S. Infection of human polyomaviruses JC and BK in peripheral blood leukocytes from immunocompetent individuals. Virology 198, 59–70 (1994).
38. Arthur, R. R., Shah, K. V., Baust, S. J., Santos, G. W. & Saral, R. Association of BK viruria with hemorrhagic cystitis in recipients of bone marrow transplants. N Engl J Med 315, 230–234 (1986).
39. Lekakis, L. J., Macrinici, V., Baraboutis, I. G., Mitchell, B. & Howard, D. S. BK virus nephropathy after allogeneic stem cell transplantation: a case report and literature review. Am J Hematol
84, 243–246 (2009).
40. Cesaro, S. et al. ECIL guidelines for the prevention, diagnosis and treatment of BK polyomavirus-associated haemorrhagic cystitis in haematopoietic stem cell transplant recipients. J Antimic-
rob Chemother 73, 12–21 (2018).
41. Leung, A. Y. H., Yuen, K.-Y. & Kwong, Y.-L. Polyoma BK virus and haemorrhagic cystitis in haematopoietic stem cell transplantation: a changing paradigm. Bone Marrow Transplant 36,
929–937 (2005).
42. Hirsch, H. H., Randhawa, P., & AST Infectious Diseases Community of Practice. BK polyomavirus in solid organ transplantation. Am J Transplant 13 Suppl 4, 179–188 (2013).
43. Borni-Duval, C. et al. Risk factors for BK virus infection in the era of therapeutic drug monitoring. Transplantation 95, 1498–1505 (2013).
44. Jandial, A., Mishra, K., Sandal, R. & Kant Sahu, K. Management of BK virus-associated haemorrhagic cystitis in allogeneic stem cell transplant recipients. Ther Adv Infect Dis 8, 2049936121991377
(2021).
45. Park, W. Y. et al. Long-term prognosis of BK virus-associated nephropathy in kidney transplant recipients. Kidney Res Clin Pract 37, 167–173 (2018).
46. Smith, J. M. et al. Polyomavirus nephropathy in pediatric kidney transplant recipients. Am J Transplant 4, 2109–2117 (2004).
47. Hart, A., Singh, D., Brown, S. J., Wang, J. H. & Kasiske, B. L. Incidence, risk factors, treatment, and consequences of antibody-mediated kidney transplant rejection: A systematic review. Clin
Transplant 35, e14320 (2021).
48. Fogeda, M. et al. Cross-sectional study of BK virus infection in pediatric kidney transplant recipients. Pediatr Transplant 11, 394–401 (2007).
49. Costa, J. et al. Oncogenicity of a nude mouse cell line transformed by a human papovavirus. J Natl Cancer Inst 58, 1147–1149 (1977).
50. Watanabe, S., Kotake, S., Nozawa, A., Muto, T. & Uchida, S. Tumorigenicity of human BK papovavirus plaque isolates, wild-type and plaque morphology mutant, in hamsters. Int J Cancer 29,
583–586 (1982).
51. Theile, M. & Grabowski, G. Mutagenic activity of BKV and JCV in human and other mammalian cells. Arch Virol 113, 221–233 (1990).
52. Cicala, C. et al. Simian virus 40 small-t antigen stimulates viral DNA replication in permissive monkey cells. J Virol 68, 3138–3144 (1994).
53. Whalen, B., Laffin, J., Friedrich, T. D. & Lehman, J. M. SV40 small T antigen enhances progression to >G2 during lytic infection. Exp Cell Res 251, 121–127 (1999).
54. Lavien, G., Alger, J., Preece, J., Alexiev, B. A. & Alexander, R. B. BK Virus-Associated Invasive Urothelial Carcinoma With Prominent Micropapillary Carcinoma Component in a Cardiac
Transplant Patient: Case Report and Review of Literature. Clin Genitourin Cancer 13, e397-399 (2015).
55. Yu, J., Boyapati, A. & Rundell, K. Critical role for SV40 small-t antigen in human cell transformation. Virology 290, 192–198 (2001).
56. Yin, W.-Y., Lee, M.-C., Lai, N.-S. & Lu, M.-C. BK virus as a potential oncovirus for bladder cancer in a renal transplant patient. J Formos Med Assoc 114, 373–374 (2015).
57. Das, D., Shah, R. B. & Imperiale, M. J. Detection and expression of human BK virus sequences in neoplastic prostate tissues. Oncogene 23, 7031–7046 (2004).
58. Imperiale, M. J. Oncogenic transformation by the human polyomaviruses. Oncogene 20, 7917–7923 (2001).
59. Vallbracht, A. et al. Disseminated BK type polyomavirus infection in an AIDS patient associated with central nervous system disease. Am J Pathol 143, 29–39 (1993).
60. Behzad-Behbahani, A., Klapper, P. E., Vallely, P. J., Cleator, G. M. & Bonington, A. BKV-DNA and JCV-DNA in CSF of patients with suspected meningitis or encephalitis. Infection 31, 374–378
(2003).
61. Behzad-Behbahani, A., Klapper, P. E., Vallely, P. J. & Cleator, G. M. BK virus DNA in CSF of immunocompetent and immunocompromised patients. Arch Dis Child 88, 174–175 (2003).
62. mutlu d et al. Quantitation of BK vırus load in serum and urine samples for the diagnosis of BK virus associated nephropathy in renal transplant recipients from Turkey. international journal
of infectious diseases 10, 20–21 (2006).
63. Dall, A. & Hariharan, S. BK virus nephritis after renal transplantation. Clin J Am Soc Nephrol 3 Suppl 2, S68-75 (2008).
64. Viscount, H. B. et al. Polyomavirus polymerase chain reaction as a surrogate marker of polyomavirus-associated nephropathy. Transplantation 84, 340–345 (2007).
65. Vögeli, T. A., Peinemann, F., Burdach, S. & Ackermann, R. Urological treatment and clinical course of BK polyomavirus-associated hemorrhagic cystitis in children after bone marrow
transplantation. Eur Urol 36, 252–257 (1999).
66. Cesaro, S. et al. Cidofovir for BK virus-associated hemorrhagic cystitis: a retrospective study. Clin Infect Dis 49, 233–240 (2009).
67. Acott, P. D. & Hirsch, H. H. BK virus infection, replication, and diseases in pediatric kidney transplantation. Pediatr Nephrol 22, 1243–1250 (2007).
68. Araya, C. E., Lew, J. F., Fennell, R. S., Neiberger, R. E. & Dharnidharka, V. R. Intermediate dose cidofovir does not cause additive nephrotoxicity in BK virus allograft nephropathy. Pediatr
Transplant 12, 790–795 (2008).
69. Hardinger, K. L. et al. Prospective, pilot, open-label, short-term study of conversion to leflunomide reverses chronic renal allograft dysfunction. Am J Transplant 2, 867–871 (2002).
70. Chong, A. S. et al. Concurrent antiviral and immunosuppressive activities of leflunomide in vivo. Am J Transplant 6, 69–75 (2006).
71. Eash, S., Manley, K., Gasparovic, M., Querbes, W. & Atwood, W. J. The human polyomaviruses. Cell Mol Life Sci 63, 865–876 (2006).
72. Padgett, B. L. & Walker, D. L. Prevalence of antibodies in human sera against JC virus, an isolate from a case of progressive multifocal leukoencephalopathy. J Infect Dis 127, 467–470 (1973).
73. Kitamura, T., Aso, Y., Kuniyoshi, N., Hara, K. & Yogo, Y. High incidence of urinary JC virus excretion in nonimmunosuppressed older patients. J Infect Dis 161, 1128–1133 (1990).
74. Vigiser, I. et al. JCV seroconversion rate during the SARS COVID-19 pandemic. Mult Scler Relat Disord 68, 104244 (2022).
75. Fang, C.-Y. et al. Unusually high incidence of polyomavirus JC infection in the higher grade of colorectal cancer tissues in Taiwan. Eur J Med Res 27, 127 (2022).
76. Wei, G., Liu, C. K. & Atwood, W. J. JC virus binds to primary human glial cells, tonsillar stromal cells, and B-lymphocytes, but not to T lymphocytes. J Neurovirol 6, 127–136 (2000).
77. Assetta, B. & Atwood, W. J. The biology of JC polyomavirus. Biol Chem 398, 839–855 (2017).
78. Padgett, B. L., Walker, D. L., ZuRhein, G. M., Eckroade, R. J. & Dessel, B. H. Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy. Lancet 1,
1257–1260 (1971).
79. Molloy, E. S. & Calabrese, L. H. Therapy: Targeted but not trouble-free: efalizumab and PML. Nat Rev Rheumatol 5, 418–419 (2009).
80. Clifford, D. B. et al. Rituximab-associated progressive multifocal leukoencephalopathy in rheumatoid arthritis. Arch Neurol 68, 1156–1164 (2011).
81. Ohsumi, S., Motoi, M. & Ogawa, K. Induction of undifferentiated tumors by JC virus in the cerebrum of rats. Acta Pathol Jpn 36, 815–825 (1986).
82. London, W. T. et al. Viral-induced astrocytomas in squirrel monkeys. Prog Clin Biol Res 105, 227–237 (1983).
83. Raj, G. et al. Characterization of glioma-cells derived from human polyomavirus-induced brain-tumors in hamsters. Int J Oncol 7, 801–808 (1995).
84. Sima, A. A., Finkelstein, S. D. & McLachlan, D. R. Multiple malignant astrocytomas in a patient with spontaneous progressive multifocal leukoencephalopathy. Ann Neurol 14, 183–188 (1983).
85. Shintaku, M., Matsumoto, R., Sawa, H. & Nagashima, K. Infection with JC virus and possible dysplastic ganglion-like transformation of the cerebral cortical neurons in a case of progressive
multifocal leukoencephalopathy. J Neuropathol Exp Neurol 59, 921–929 (2000).
86. Del Valle, L. et al. Detection of JC virus DNA sequences and expression of the viral regulatory protein T-antigen in tumors of the central nervous system. Cancer Res 61, 4287–4293 (2001).
87. Gray, F. et al. Central nervous system immune reconstitution disease in acquired immunodeficiency syndrome patients receiving highly active antiretroviral treatment. J Neurovirol 11 Suppl
3, 16–22 (2005).
88. Krumbholz, A., Bininda-Emonds, O. R. P., Wutzler, P. & Zell, R. Evolution of four BK virus subtypes. Infect Genet Evol 8, 632–643 (2008).
89. Helle, F. et al. Biology of the BKPyV: An Update. Viruses 9, 327 (2017).